Protocol for a systematic review on routine use of antibiotics for infants less than 6 months of age with growth

Aamer Imdad1, Fanny F Chen2, Melissa François2

  • 1Division of Pediatric Gastroenterology, Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA imdada@upstate.edu.

BMJ Open
|June 30, 2022
PubMed

Insights

This systematic review examines antibiotic effectiveness for infants under six months experiencing growth faltering. Evidence is limited, highlighting the need for better treatment guidelines for this vulnerable population.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Antibiotics are used for severe acute malnutrition in children (6-59 months).
  • Data on antibiotic use for infants under six months with growth failure is scarce.
  • The World Health Organization (WHO) is developing guidelines for infant wasting and growth faltering.

Purpose of the Study:

  • To systematically review and synthesize current evidence on antibiotic effectiveness in treating infants under six months with growth failure/faltering.
  • To inform WHO guideline development for preventing and treating wasting in young infants.
  • To address the lack of data for this specific age group.

Main Methods:

  • Systematic review and meta-analysis of randomized controlled trials and non-randomized studies with a control arm.
  • Searches across multiple electronic databases.
  • Inclusion criteria: infants < 6 months with growth failure; intervention: no/alternative antibiotics; comparison: WHO 2013 guideline antibiotics.
  • Outcomes include mortality, clinical deterioration, antimicrobial resistance, and adverse events.

Main Results:

  • The review synthesizes evidence from eligible studies.
  • Meta-analysis will be used to pool data where applicable.
  • Evidence quality will be assessed using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) approach.

Conclusions:

  • Findings will be published in a peer-review journal.
  • The review will guide WHO recommendations on antibiotic use in infants < 6 months with growth failure.
  • This research addresses a critical knowledge gap in pediatric nutrition and infectious disease management.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
55.1K
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
979
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.8K
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
155
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
192